Reaction to this week's political shocks, why many conservatives are choosing to double down on Trump critics, and then, a conversation on the growing dis-union in America.
A panel talks about changes in how drugs are marketed, from direct-to-consumer ads to patient education and support groups funded by pharmaceutical companies.
- Dr. Adrian Di Bisceglie Medical director of the American Liver Foundation and professor of internal medicine at St. Louis University
- Mary Nell Lenhard Senior vice president for policy and representation at the Blue Cross Blue Shield Association
- Dr. Michael Shaw Executive director of EthicAd, a nonprofit group formed to create standards for direct-to-consumer drug ads
- Dr. Thomas Murray Fellow at the Hastings Center
Most Recent Shows
Political fallout from the dismissal of FBI director James Comey, how our government created racially segregated cities, and a young Palestinian's perspective on Mideast peace.
Washington Post reporter Dan Balz on covering President Trump and linguist Deborah Tannen on how women support each other with the words they use.
American University history professor Allan Lichtman describes how and why President Donald Trump could be impeached, and then, Pulitzer Prize winning writer Elizabeth Strout on her new book, "Anything is Possible".